WebSep 9, 2024 · Abstract. Objective: To compare the patency control of dysfunctioning forearm arteriovenous graft (AVG) using percutaneous transluminal angioplasty (PTA) in patients with loop versus straight grafts. Materials and Methods: Between January 2012 and March 2024, hemodialysis patients with forearm AVG were treated with PTA at two hospitals. We … WebOct 1, 2006 · Patency rates of arteriovenous fistulae after 6 months, 2 years and 5 years. For primary and secondary patency rates survival analysis with Log rank test. Figures - uploaded by Cevdet Kocogullari
Vascular Patency - an overview ScienceDirect Topics
WebSep 24, 2024 · The primary efficacy endpoint was primary patency (defined as a peak systolic velocity ratio ≤2·4, without clinically driven target lesion revascularisation or bypass of the target lesion) and the primary safety endpoint was major adverse events (ie, all causes of death through 1 month, major amputation of target limb through 12 months, … WebThe primary patency rates were, 76%, 67%, and 60% at 3, 9, and 12 months, respectively. There were 10 (24.4%) patients with thrombosis and 2 (4.8%) patients with bleeding. Graft … bakugan wiki gate cards
Transit time flow measurement predicts graft patency in off-pump ...
WebFeb 11, 2024 · The evidence in our review is current until 13 March 2024. From our analysis, we found that grafts made from a person's own vein had a better primary patency (blood flow) rate than the prosthetic materials PTFE or Dacron for above-knee bypass grafts. Meanwhile, Dacron (and possibly also human umbilical vein) achieved better blood flow … WebPrimary, primary assisted, and secondary patency rates were calculated. Multivariate analysis was used to identify factors of influence on survival. Incidence rates of … WebThe secondary patency rate of blind bypass grafts was no different from that of grafts with at least 1 patent outflow vessel (67% ± 7% vs 64% ± 4%; P was not significant). However, the 2-year limb salvage rate in limbs with blind outflow was significantly worse than in limbs with at least 1 patent outflow vessel (67% ± 7% vs 76% ± 3%; P = .04). bakugan wiki characters